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Abstract 24 
Clostridium beijerinckii is a potentially important industrial microorganism as it can 25 
synthesize valuable chemicals and fuels from various carbon sources. The 26 
establishment of convenient to use, effective gene tools with which the organism can 27 
be rapidly modified is essential if its full potential is to be realized. Here, we developed 28 
a genomic editing tool (pCBEclos) for use in C. beijerinckii based on the fusion of 29 
cytidine deaminase (Apobec1), Cas9D10A nickase and uracil DNA glycosylase inhibitor 30 
(UGI). Apobec1 and UGI are guided to the target site where they introduce specific 31 
base-pair substitutions through the conversion of C·G to T·A. By appropriate choice of 32 
target sequence, these nucleotide changes are capable of creating missense mutation or 33 
null mutations in a gene. Through optimization of pCBEclos, the system derived, 34 
pCBEclos-opt, has been used to rapidly generate four different mutants in C. 35 
beijerinckii, in pyrE, xylR, spo0A and araR. The efficiency of the system was such that 36 
they could sometimes be directly obtained following transformation, otherwise only 37 
requiring one single re-streaking step. Whilst CRISPR-Cas9 nickase systems, such as 38 
pNICKclos2.0, have previously been reported in C. beijerinckii, pCBEclos-opt does 39 
not rely on homologous recombination, a process that is intrinsically inefficient in 40 
clostridia such as C. beijerinckii. As a consequence, bulky editing templates do not need 41 
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to be included in the knock-out plasmids. This both reduces plasmid size and makes 42 
their construction simpler, e.g., whereas the assembly of pNICKclos2.0 requires six 43 
primers for the assembly of a typical knock-out plasmid, pCBEclos-opt requires just 44 
two primers. The pCBEclos-opt plasmid established here represents a powerful new 45 
tool for genome editing in C. beijerinckii, which should be readily applicable to other 46 
clostridial species.  47 
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1 Introduction 51 
Clostridium beijerinckii, a spore-forming, solventogenic, Gram-positive 52 
bacterium, is a potentially important industrial strain as it can utilize a variety of carbon-53 
based feedstocks to generate valuable chemicals and fuels (Chen & Blaschek, 1999; 54 
Dürre, 1998; Ezeji, Qureshi, & Blaschek, 2007; Y. Gu, Jiang, Yang, & Jiang, 2014; 55 
Jiang, Liu, Jiang, Yang, & Yang, 2015; Lee et al., 2008; Thakker, Martinez, Li, San, & 56 
Bennett, 2015). The establishment of convenient to use, effective gene tools with which 57 
the organism can be rapidly modified is essential if its full potential is to be realized. 58 
Such tools may be used both to provide an in-depth understanding of cell physiology 59 
and to enable the robust construction of engineered process organisms. Several genomic 60 
editing tools have been developed in C. beijerinckii. Till now, a commonly used 61 
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procedure is based on gene inactivation by group II introns, typified by 62 
Clostron/Targetron technology (Heap et al., 2010; Heap, Pennington, Cartman, Carter, 63 
& Minton, 2007; Shao et al., 2007). Here the presence of intron-encoding protein allows 64 
a mobile group II intron to recognize and insert into a specific site of the genome, 65 
resulting in gene disruption. Although Clostron/Targetron technology is effective, it 66 
cannot achieve in-frame deletion, large fragment insertion or base editing. Moreover, 67 
in common with any insertional mutagen, it can result in polar effects. 68 
Traditional homologous recombination-dependent allelic exchange may also be 69 
employed to edit C. beijerinckii genomes. Its application is reliant on the sequential 70 
occurrence of single crossover and double crossover events. These occur naturally, but 71 
at a very low frequency. According those cells in which the desired crossovers have 72 
taken place need to be detected in the wild type population through the use of 73 
appropriate selective tools. The latter have included the use of counter selection 74 
markers (Al-Hinai, Fast, & Papoutsakis, 2012) or I-SceI endonuclease (N. Zhang et al., 75 
2015). Their use, however, is somewhat laborious, involving numerous re-streaking of 76 
colonies onto the necessary selective media, and their effectiveness can suffer from a 77 
high background of false positives due to spontaneous mutants. A more effective means 78 
of selecting the required double crossover mutants is to use CRISPR-Cas9 where the 79 
wild type cells are eliminated on mass leaving only the desired mutant cells. In such a 80 
system, typified by the previously described C. beijerinckii CRISPR-Cas9D10A genome 81 
editing tool (Li et al., 2016), all colonies obtained following transformation are in 82 
 5 
essence mutants. However, whilst the use of CRISPR-Cas9 offers significant advantage 83 
over the use of other counter selection markers, it remains reliant on homologous 84 
recombination (HR), which is notoriously inefficient in clostridia and therefore reliant 85 
on highly efficient DNA transfer. As the frequency of DNA transfer is inversely 86 
proportional to plasmid size, the need to incorporate large editing templates in CRISPR-87 
Cas9 vectors for the purposes of HR compromise the system. Moreover, the inclusion 88 
of an editing template in the design of the knock-out plasmid adds complexity, requiring 89 
at least six primers for the assembly of the vector (Li et al., 2016). As the consequence 90 
that the availability of a HR-independent C. beijerinckii genomic editing tool that 91 
would involve fewer steps for assembly, and use relatively smaller vectors conducive 92 
to high transformation frequencies, is highly desirable. 93 
In recent years, the utility of CRISPR-Cas in genome editing has been extended 94 
through its combination with deaminase enzymes to create a novel strategy for strain 95 
engineering which is not reliant on HR. Cytidine deaminase or adenine deaminase is 96 
fused to Cas9 effector protein (Cas9 nickase or dCas9) which allows its delivery to the 97 
intended DNA target sites by the sgRNA/Cas9 complex. Upon delivery, the deaminase 98 
converts nucleotide base pairs C·G to T·A or A·T to G·C. These conversions take place 99 
in the absence of Cas9-mediated DNA double-stranded breaks (DSB) while the plasmid 100 
employed do not require the relatively large editing templates associated with 101 
traditional CRISPR-Cas9 genome editing vectors. To date, the base conversion activity 102 
of cytidine deaminase and adenine deaminase has been used in prokaryotes (Banno, 103 
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Nishida, Arazoe, Mitsunobu, & Kondo, 2018; Gaudelli et al., 2017; T. Gu et al., 2018; 104 
Wang, Liu, et al., 2018; Wang, Wang, et al., 2018; Zheng et al., 2018) and eukaryotes 105 
(K. Kim et al., 2017; Y. B. Kim et al., 2017; Komor, Kim, Packer, Zuris, & Liu, 2016; 106 
Nishida et al., 2016; Rees et al., 2017; Y. Zhang et al., 2017; Zong et al., 2017), but no 107 
deaminase was applied in Clostridium species.  108 
In this study, we established a base editing tool (pCBEclos) in C. beijerinckkii 109 
NCIMB 8052 by the fusion of Cas9D10A nickase, cytidine deaminase (rat Apobec1) and 110 
uracil DNA glycosylase inhibitor (UGI) which was able to efficiently convert specific 111 
C·G nucleotide base pairs in the target window sequence to T·A. In its optimized form 112 
(pCBclos-opt) it proved possible to rapidly generate mutants in four different genes, 113 
namely pyrE, xylR, spo0A and araR. The system does not rely on HR, a process that is 114 
intrinsically inefficient in clostridia such as C. beijerinckii. As a consequence, bulky 115 
editing templates do not need to be included in the knock-out plasmids. This both 116 
reduces plasmid size and makes their construction simpler, e.g., whereas the assembly 117 
of pNICKclos2.0 requires six primers for the assembly of a typical knock-out plasmid, 118 
pCBEclos-opt requires just two primers.  119 
To our knowledge, this is the first report of the successful application of the 120 
Cas9D10A nickase and deaminase mediated base editing in Clostridium. It represents a 121 
powerful new tool for genome editing in C. beijerinckii, which should be readily 122 
applicable to other clostridial species.  123 
 124 
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2 Materials and Methods 125 
2.1 Bacterial strains, media and reagents 126 
The bacterial strains used in this study are listed in the Supporting information, Table 127 
S1. Escherichia coli DH5α was used for plasmid construction and maintenance. It was 128 
grown in LB medium at 37℃, supplemented where necessary with ampicillin (100 129 
μg/ml). C. beijerinckii NCIMB 8052 was used as genome editing strain, it was grown 130 
in CGM medium at 37℃ in anaerobic chamber (Thermo Forma, Inc., Waltham, MA, 131 
USA). 20 μg/ml of erythromycin was supplemented as needed for plasmid selection. 132 
For C. beijerinckii NCIMB 8052 pyrE mutant, 20 μg/l uracil was required in CGM 133 
medium. 134 
The DNA polymerase KOD plus Neo and KOD FX (Toyobo, Osaka, Japan) were 135 
used for high fidelity DNA amplification and colony PCR, respectively. All restriction 136 
enzymes used in this study were purchased from Thermo Fisher Scientific (USA). The 137 
plasmids used in this study were assembled by ClonExpress One Step Cloning Kit 138 
(Vazyme Biotech Co., Ltd, Nanjing, China). DNA purification and plasmids extracting 139 
were performed by kits purchased from Axygen (Hangzhou, China). 140 
2.2 Plasmid construction 141 
Cas9D10A nickase and Pthl were amplified from the plasmid pNICKclos2.0 (Li et al., 142 
2016) by primers BE-Pthl-up/BE-Pthl-dn (apo-hm) and Cas9nclos-up/Cas9nclos-dn 143 
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respectively. The plasmid #73021 purchase from Addgene was used as the template to 144 
amplify the Apobec1 and UGI gene by primers Apobec1-hm-up/Apobec1-hm-dn and 145 
UGI-hm-up/UGI-hm-dn. The design guideline for sgRNA is as follows: 1. Choose 5’-146 
NGG-3’ protospacer-adjacent motif (PAM); 2. The window area (typically from 147 
positions 4 to 8 within the N20, counting the end distal PAM to the as position 1) must 148 
containing C; 3. Base immediately 5’of the target C should be TC ≥ CC ≥ AC > GC 149 
(Komor et al., 2016). The primers cbei1006-gRNA1-up1/BE-gRNA-dn were first used 150 
to amplify the Pj23119-sgRNA-pyrE cassette from pNICKclos2.0 which was then used 151 
as the template with primers cbei1006-gRNA1-up2/BE-gRNA-dn to produce the 152 
overlapping extensions at the 5’ ends of the Pj23119-sgRNA-pyrE cassette. Then, Pj23119-153 
sgRNA-pyrE cassette, Pthl, Apobec1, Cas9
D10A nickase and UGI were fused with 154 
BamHI/SmaI linearized pXY1 to generated plasmid pCBEclos-cbei1006-g1. Plasmids 155 
pCBEclos-cbei1006-g2 and pCBEclos-cbei1006-g3 were derived from pCBEclos-156 
cbei1006-g1 by replacing the 20-bp target sequences. The construction of plasmid 157 
pCBEclos-cbei1006-g2 has been shown here as an example. Fragment cbei1006-158 
gRNA2-A was amplified from plasmid pCBEclos-cbei1006-g1 by primers cbei1006-159 
gRNA2-up(A-up)/pBEclos-A-dn. Primers pBEclos-B-up/pBEclos-B-dn, pBEclos-C-160 
up/pBEclos-C-dn were used to amplify the fragments BEclos-B, BEclos-C from 161 
pCBEclos-cbei1006-g1. cbei1006-gRNA2-A, BEclos-B and BEclos-C were assembled 162 
together to yield plasmid pCBEclos-cbei1006-g2. Among them, the fragments BEclos-163 
B and BEclos-C were universal, only the fragment A (e.g. cbei1006-gRNA2-A) was 164 
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changed for each new plasmid (Fig. S1). For example, during the construction of 165 
plasmid pCBEclos-cbei1006-g3, only the primers cbei1006-gRNA3-up (A-166 
up)/pBEclos-A-dn were used to amplified the fragment cbei1006-gRNA3-A, then this 167 
fragment was fused with previously amplified fragments BEclos-B and BEclos-C to 168 
generate the plasmid pCBEclos-cbei1006-g3. 169 
Codon optimization of genes Apobec1 and UGI were performed by GenScript 170 
Biotech Corp in Nanjing. Primers Apobec1-opt-up/Apobec1-opt-dn, UGI-opt-up/UGI-171 
opt-dn were adopted to amplify the optimized Apobec1 and UGI genes respectively. 172 
Cas9D10A nickase was amplified from the plasmid pNICKclos2.0 by primers Cas9nclos-173 
up (for opt)/Cas9nclos-dn (for opt). Apobec1, UGI and Cas9D10A nickase amplified here 174 
were fused with BamH/SmaI linearized pCBEclos-cbei1006-g1 to generated plasmid 175 
pCBEclos-cbei1006-g1-opt. 176 
Plasmid pCBEclos-cbei1006-g2-opt, pCBEclos-cbei1006-g3-opt, pCBEclos-177 
cbei4456-opt, pCBEclos-cbei2385-g1-opt, pCBEclos-cbei2385-g2-opt (Addgene 178 
deposits No. 118215) and pCBEclos-cbei1712-opt were derived from pCBEclos-179 
cbei1006-g1-opt by replacing the 20-bp target sequences. The construction process of 180 
these plasmids was similar to the unoptimized pCBEclos series of plasmids. Here, only 181 
the construction of plasmid pCBEclos-cbei1712-opt has been shown as an example. 182 
Fragment cbei1712-gRNA-A was amplified from plasmid pCBEclos-cbei1006-g1-opt 183 
by primers cbei1712-gRNA-up(A-up)/pBEclos-A-dn. Primers pBEclos-B-184 
up/pBEclos-B-dn, pBEclos-C-up/pBEclos-C-dn were used to amplify the fragments 185 
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BEclos-B-opt, BEclos-C-opt from pCBEclos-cbei1006-g1-opt. cbei1712-gRNA-A, 186 
BEclos-B-opt and BEclos-C-opt were assembled together to yield plasmid pCBEclos-187 
cbei1712-opt. Similarly, the fragments BEclos-B-opt and BEclos-C-opt were universal 188 
for constructing the optimized pCBEclos series of plasmids (Fig. S1). 189 
2.3 Electroporation and screening of mutant strains 190 
Plasmids were transformed into C. beijerinckii NCIMB 8052 using a previously 191 
reported electroporation protocol (Mermelstein, Welker, Bennett, & Papoutsakis, 1992). 192 
The recovered cells were spread on CGM agar supplemented with an appropriate 193 
amount of erythromycin and incubated at 37℃ for approximately 2 days. The primers 194 
listed in the Supplementary Table S2 were used for colony PCR, which was undertaken 195 
when the transformants were visible on the CGM agar plates. Then, the PCR products 196 
were extracted and sequenced to confirm the desired mutation events. For screening of 197 
the pyrE mutants, the CGM medium was supplemented with 400 μg/l 5-fluroorotic acid 198 
(5-FOA). Colony PCR was undertaken on a selection of random colonies growing on 199 
the CGM agar containing 5-FOA, to confirm the expected mutation. 200 
2.4 Plasmid curing 201 
To eliminate the plasmids used in this study, mutants were first cultivated in 5 ml of 202 
CGM medium without any antibiotic (T1). After growing for 12 h, 50 μl of the T1 broth 203 
was used to inoculate 5 ml of fresh CGM medium and grown for 12 h until the OD600 204 
reached 0.8. The culture was diluted appropriately and aliquots of cells spread on a 205 
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nonselective CGM agar plate. The individual colonies were patch plated onto CGM 206 
agar with and without erythromycin (20 μg/ml). The cells that grew on nonselective 207 
medium, but were unable to grow on erythromycin CGM agar, were deemed to have 208 
been cured of their plasmids. 209 
2.5 Fermentation and data analysis 210 
The fermentation of strains 8052WT, 8052xylR(TargeTron) (Xiao et al., 2012) and 211 
8052xylR(BE)( xylR was disrupted by pCBEclos-opt) were performed anaerobically in 212 
XHP2 medium (Xiao et al., 2012) at 37℃ with xylose(60 g/l) as the carbon source for 213 
72 h. 5 ml of liquid CGM was inoculated with single colony at 37 °C for about 12h, 214 
then ~5% (v/v) of the inoculum was transferred into XHP2 medium for fermentation 215 
when the optical density at 600 nm (OD600) of the cells reached 0.8–1.0. The 216 
concentrations of xylose were determined with high-performance liquid 217 
chromatography (1200 series; Agilent), as described previously (Ren et al., 2010). Cell 218 
density (OD600) was measured using a DU730 spectrophotometer (Beckman Colter).  219 
 220 
3 Results 221 
3.1 Establishment of CRISPR-Cas9D10A nickase-mediated base editing system 222 
pCBEclos-opt in C. beijerinckii NCIMB 8052 223 
To employ the deaminase-mediated base editing in C. beijerinckii NCIMB 8052, 224 
 12 
we combined all functional components of the desired system into a single plasmid, 225 
pCBEclos (Figure 1A). Transcription of the sgRNA was placed under the control of the 226 
Pj23119 promoter, and expression of the fusion protein of deaminase (rat Apobec1), 227 
Cas9D10A nickase and UGI under the control of the Pthl promoter. Cas9
D10A nickase 228 
targets the non-edited strand and generates a nick, which promotes the use of the edited 229 
strand as template for the repair of the nicked strand (Komor et al., 2016; Komor et al., 230 
2017). UGI suppresses excision of the uracil base generated by the cytosine deaminase 231 
and accelerates mutagenesis (Banno et al., 2018; Komor et al., 2017) (Figure 1A). To 232 
verify the desired mutation events generated via plasmid pCBEclos, DNA fragments 233 
amplified by colony PCR of cells growing on counter selective media were subject to 234 
Sanger sequencing for verifying the counter-selective genes; and colony PCR and 235 
sequencing were directly performed from the transformants for non-selectable genes 236 
(Figure 1B).  237 
The pyrE gene (cbei1006) encoding orotate phosphoribosyltransferase was 238 
selected as the first target gene in C. beijerinckii NCIMB 8052. Inactivation of the pyrE 239 
gene leads to uracil auxotrophy and to resistance to the uracil analog 5-FOA (Ehsaan et 240 
al., 2016; Tripathi et al., 2010), making such mutants readily distinguishable from wild 241 
type cells. Accordingly, the plasmid pCBEclos-cbei1006-g1 carrying the spacer that 242 
targets the pyrE gene was electroporated into C. beijerinckii NCIMB 8052 and a total 243 
of 55 transformants from those obtained on CGM media supplemented with 244 
erythromycin. To establish if any of these transformants were mutants, a total of 20 245 
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randomly selected colonies were subject to colony PCR and the amplified DNA 246 
fragment subject to Sanger sequencing. All of the sequence reads obtained were wild 247 
type. To ascertain whether mutant cells were present within the population, all of the 248 
55 primary transformants were patch plated onto CGM agar media supplemented with 249 
5-FOA. Of these, 22 were found to be resistant to 5-FOA. However, even after an 250 
extended period of time, these colonies grew poorly (Figure 2A). Further screening of 251 
a randomly selected 9 representatives of these 22 clones by Sanger sequencing of the 252 
DNA fragment amplified by colony PCR indicate that all 9 contained the expected 253 
mutational change (Figure 2B).   254 
Our hypothesis to explain this observation is that the initial transformant colonies 255 
are composed of a mixture of wild type and mutant cells in which the former vastly 256 
predominate. The ratio of mutant to wild type is such that the mutant sequence cannot 257 
be detected as it is swamped by the wild type. As an additional consequence, the 258 
transformants grow poorly when initially plated on agar media containing 5-FOA as 259 
they are predominately wild type cells, which are sensitive to this uracil analog. 260 
Additionally, vector maintenance and constitutive expression of the codon un-261 
optimized fusion protein might also be responsible for reduced growth. Thus, our initial 262 
base editing system (designated pCBEclos) although functional in C. beijerinckii 263 
NCIMB 8052, was deemed relatively inefficient. 264 
We also selected two other target sites (Fig. S2A) within the pyrE gene to test 265 
pCBEclos. Similar to pCBEclos-cbei1006-g1, 20 out of 22 transformants obtained with 266 
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plasmid pCBEclos-cbei1006-g2 were found to grow on CGM agar containing 5-FOA, 267 
albeit weakly. In contrast, no cells resistant to 5-FOA were obtained with plasmid 268 
pCBEclos-cbei1006-g3 (Fig. S2B). 9 out of those 20 clones obtained from pCBEclos-269 
cbei1006-g2 which grew on 5-FOA medium were all shown by Sanger sequencing of 270 
amplified PCR products, to contained the desired mutations (Fig. S2C). The results 271 
indicated that the selection of different target sites on the same gene was not a fruitful 272 
way to improve the efficiency of the initially established base editing plasmid 273 
pCBEclos. 274 
As the Addgene-derived Apobec1 and UGI genes used in the pCBEclos plasmid 275 
system were optimized for expression in human cells, they may not be well expressed 276 
in Clostridium. This could explain the poor efficiency of pCBEclos. Accordingly, we 277 
elected to optimize the Apobec1 and UGI codons used based on C. beijerinckii NCIMB 278 
8052 genome codon usage. The humanized components on plasmid pCBEclos-279 
cbei1006-g1 were thereafter replaced with the Clostridium optimized Apobec1 and 280 
UGI genes to generate plasmid pCBEclos-cbei1006-g1-opt. Following the procedure 281 
showed in Figure 1B, plasmid pCBEclos-cbei1006-g1-opt was electroporated into C. 282 
beijerinckii NCIMB 8052 and transformed cells plated onto CGM agar supplemented 283 
with erythromycin. The transformation frequencies obtained equated to 18.2 CFU/μg 284 
DNA. Sanger sequencing of the amplified DNA obtained by colony PCR of six 285 
randomly selected transformants revealed that three of them contained the desired 286 
mutational changes. However, the reads obtained comprised a mixture of wild type and 287 
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mutant reads in the target region (Figure 3A). These cells were therefore re-streaked 288 
once onto fresh CGM agar plates and two of single colonies tested again by Sanger 289 
sequencing of the PCR amplified product. All of the purified colonies appeared to be 290 
clean mutants with no detectable wild type sequence (Figure 3C). In parallel to the 291 
above, 49 primary pCBEclos-cbei1006-g1-opt transformants were patch plated onto 292 
CGM agar containing 5-FOA. On the basis of their growth, 46 out of the 49 colonies 293 
were found to be resistant to 5-FOA. Moreover, in this case the growth observed was 294 
vigorous, in contrast to the poor growth previously obtained when using the un-295 
optimized pCBEclos system (Figure 3B). The new base editing tool was designation 296 
the pCBEclos-opt system. In contrast to pCBEclos, clones containing the desired C·G 297 
to T·A mutations obtained simply by plating cells electroporated with the pCBEclos-298 
opt system onto CGM media containing erythromycin. The detection of the desired 299 
mutants using the pCBEclos system requires subsequent screening of primary 300 
transformants on selective media (Figure 3D). Moreover, the ratio of positive 5-FOA 301 
resistant colonies was improved by about 2-folds via pCBEclos-opt system, compared 302 
to the previous pCBEclos system (Figure 3D).  303 
Successive rounds of base editing require that the initially used editing plasmid is 304 
cured from the cell if an additional mutation is required. In order to test the efficiency 305 
of plasmid curing, the edited C. beijerinckii NCIMB 8052 containing the expected pyrE 306 
mutation was cultured in nonselective liquid CGM that was supplemented with 307 
exogenous uracil (20 μg/l). After two subcultures, clonal populations were isolated by 308 
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plating to single colonies on nonselective CGM plates and these single colonies were 309 
patch plated onto CGM agar with and without erythromycin supplementation. The 310 
result showed that all 56 colonies could grow on the nonselective CGM medium, but 311 
they were sensitive to erythromycin (Fig. S3). These data indicated that curing of 312 
plasmid pCBEclos-cbei1006-g1 from the cells took place with 100% efficiency after 313 
only two subcultures. 314 
3.2 Expansion of the pCBEclos-opt system to further genes in C. beijerinckii 315 
NCIMB 8052. 316 
After demonstrating the functionality of cytidine deaminase-based gene editing on 317 
the pyrE gene, we further expanded the pCBEclos-opt system to other genes in C. 318 
beijerinckii NCIMB 8052 (namely: araR or cbei4456, encoding a GntR family 319 
transcriptional regulator; xylR or cbei2385, encoding the transcriptional regulator of 320 
xylose metabolism; and spo0A or cbei1712, encoding response regulator receiver 321 
protein). 322 
Accordingly, C. beijerinckii NCIMB 8052 was transformed with plasmid 323 
pCBEclos-cbei4456-opt encoding a sgRNA that targets araR. In this case all 3 324 
transformants obtained harbored the desired C·G to T·A mutation. However, as with 325 
pyrE, all three represented a mixed population composed of the wild type and desired 326 
mutant (Figure 4A). One pure colony harboring the desired mutation could be isolated 327 
after single-round re-streaking of one of the transformants (Figure 4B).  328 
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 The plasmid pCBEclos-cbei2385-g1-opt targeting xylR was transformed in C. 329 
beijerinckii NCIMB 8052 and yielded 3 transformants that were screened by colony 330 
PCR and Sanger sequencing. The sequencing results showed that 2 transformants were 331 
mixtures (Figure 4C), while the last colony was wild-type. A pure mutant could be 332 
obtained by single-round re-streaking one of the mixed colonies on the CGM agar 333 
(Figure 4D). 334 
In the case of the xylR gene, further improvements in mutagenesis efficiency were 335 
sought by changing the target sequence of pCBEclos-opt. Accordingly, the 20-bp spacer 336 
on plasmid pCBEclos-cbei2385-g1-opt was replaced to yield pCBEclos-cbei2385-g2-337 
opt. The latter was found to be electroporated into 8052 with efficiency of 29.8 CFU/μg 338 
DNA. Sanger sequencing of the colony PCR product of five randomly selected 339 
transformants showed that one of them was a pure mutant (Figure 5A), one was a 340 
mixture and the other three were wild type. As previously, re-streaking of a mixed clone 341 
onto CGM agar and subsequent testing of individual single colonies easily allowed the 342 
isolation of a pure mutant (Fig. S4A). Thus, in contrast to the previous plasmid targeting 343 
xylR, pCBEclos-cbei2385-g1-opt, changing the target site to that present in pCBEclos-344 
cbei2385-g2-opt allowed the direct isolation of a pure mutant. As xylR was inactivated 345 
via TargeTron previously (Xiao et al., 2012) and it was related to xylose consumption. 346 
In order to test the fermentation phenotype of xylR mutant we obtained by pCBEclos-347 
opt, we fist cleared the plasmid pCBEclos-cbei2385-g2-opt with efficiency of 34/39 to 348 
obtain the strain 8052xylR(BE) (Fig. S5A). Then, 8052WT, 8052xylR(BE) as well as 349 
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8052xylR(TargeTron) (Xiao et al., 2012) were cultured in XHP2 medium containing 60 350 
g/l xylose for 72h. The results showed that the fermentation phenotype of 8052(BE) 351 
was close to the 8052xylR(TargeTron), both mutants consumed 10% more xylose than 352 
strain 8052WT (Fig. S5B). 353 
Attempting to edit spo0A, plasmid pCBEclos-cbei1712-opt was introduced into 354 
8052, and transformants were obtained with transformation of 110.6 CFU/μg DNA. 2 355 
out of 6 random picked colonies were pure mutated colonies, 3 were mixed colonies, 356 
and 1 was pure wild type (Figure 5B). Pure mutated strains could be isolated from all 357 
3 mixed colonies (Fig. S4B).  358 
 359 
4 Discussion 360 
Genome editing tools based on CRISPR-Cas9 systems traditionally introduce a 361 
DSB at a specific locus under the guidance of a sgRNA. During the repair of the DSB, 362 
precise genome editing can be achieved in the presence of a donor DNA template by 363 
exploiting the host’s homologous recombination mechanisms. Based on this principle, 364 
CRISPR-Cas9 mediated genome editing has been widely used in bacteria. However, 365 
some bacteria have inefficient HR system and lack a functional non-homologous end 366 
joining (NHEJ) repair pathway, which prevents the repair of Cas9-mediated DSBs and 367 
results in cell death. Therefore, it is necessary to establish HR independent genome 368 
editing tools in such bacteria. C. bejerinckii NCIMB 8052 is one of these bacteria 369 
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lacking an effective DSB repair pathway. One such HR independent tool available in 370 
C. bejerinckii NCIMB 8052 is the group II intron-based gene inactivation, but it is as 371 
precise as Cas9-mediated genome editing and it has polar effects. 372 
In this study, we first established a CRISPR-mediated base editing tool pCBEclos 373 
in Clostridium by the fusion of Apobec1, Cas9D10A nickase and UGI. The conversion 374 
of C·G to T·A at the target sites were realized via pCBEclos in C. bejerinckii NCIMB 375 
8052. We initially established the pCBEclos system by directly applying Apobec1 and 376 
UGI obtained from Addgene. However, the pCBEclos plasmid was inefficient and it 377 
required selective medium to screen the edited strains, such as culturing the pyrE 378 
mutants on 5-FOA plates. This pCBEclos system with poor efficiency is not suitable 379 
for genes that do not exhibit a selectable phenotype. Fortunately, the base editing 380 
efficiency was greatly improved after the optimization of Apobec1 and UGI, and the 381 
desired mutants of pyrE、xylR、spo0A or araR could be directly detected in the 382 
transformants of C. bejerinckii NCIMB 8052 via this optimized pCBEclos-opt system. 383 
Furthermore, the loss of plasmid pCBEclos-cbei1006-g1-opt after gene editing was 384 
achieved with efficiency of 100% after only two subcultures, allowing for successive 385 
rounds of base editing. When mixed colonies of wild-type cells and mutants were 386 
obtained, pure colonies harboring the desired mutation could be isolated by subsequent 387 
re-streaking of the mixed colonies. Targeting a different locus within the xylR allowed 388 
to isolate pure colonies of the desired genotype without the need of a re-streak. This 389 
improvement in mutagenesis efficiency might reinforce the hypothesis of Komor et al 390 
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(2016), that the base immediately 5’ and 3’ of the target C may result in the different 391 
editing efficiency. 392 
The whole process of Cas9D10A nickase-mediated base editing, including 393 
electroporation, editing, identification and plasmid curing, only took five days. Unlike 394 
the pNICKclos2.0 system we established previously, pCBEclos-opt does not rely on 395 
homologous recombination, and as such DNA repair templates are not required when 396 
using this system to edit gene. Therefore, the assembly of pCBEclos-opt is easier than 397 
pNICKclos2.0, requiring only two primers instead of six. PCR amplification is 398 
performed to obtain the part A that contains the new 20-bp target sequence, then this 399 
part A is fused with the universal part B and C to generate the new plasmid (Fig. S1) 400 
using ClonExpress One Step Cloning Kit. Its high genome editing efficiency of and the 401 
simplicity of its assembly make pCBEclos-opt a useful genome editing tool in 402 
Clostridium. If mutagenesis efficiency can be improved, a plasmid library of 403 
pCBEclos-opt containing sgRNAs targeting each gene in C. bejerinckii NCIMB 8052 404 
could be used to produce a mutant library that could be selected against a desired 405 
phenotype.   406 
In summary, this study is the first report that successfully applied Cas9D10A 407 
nickase-mediated base editing tool in Clostridium. A similar strategy would likely be 408 
effective in other Clostridium strains. The base editing plasmid pCBEclos-opt we 409 
established here will accelerate the metabolic engineering of Clostridium for the 410 
optimization of chemicals and solvents in the future.  411 
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 543 
Figure legends 544 
Figure 1: Base editing in C. beijerinckii NCIMB 8052. (A) Design and strategy for 545 
CRISPR-Cas9D10A nickase-mediated C·G to T·A conversion in C. beijerinckii. Guide 546 
RNA, Apobec1, Cas9D10A nickase and UGI are all expressed on one plasmid pCBEclos. 547 
(B) The procedure for confirming the mutant strain edited by pCBEclos in C. 548 
beijerinckii. After assembly of pBEclos, it is electroporated into C. beijerinckii NCIMB 549 
8052 and cells are plated on CGM plates with erythromycin to select for pBEclos. In 550 
the case of pyrE mutagenesis, an additional selection step is carried out by patching 551 
single colonies on CGM plates with erythromycin and 5-FOA. Colonies from both the 552 
transformation plate and the mutant selection plate are finally screened by PCR 553 
amplification and subsequent Sanger sequencing. When revealed by the sequencing 554 
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results, mixed colonies are re-streaked on CGM plates with appropriate antibiotic for 555 
isolation of pure colonies and re-sequencing. 556 
 557 
Figure 2: Mutagenesis of pyrE gene in C. beijerinckii NCIMB 8052 via pCBEclos 558 
system. (A) C. beijerinckii were spread on CGM plates containing 5-FOA after 559 
transformation with plasmid pCBEclos-cbei1006-g1, “-” represents the negative 560 
control; (B) Sequence alignment of the pyrE mutants edited by pCBEclos system after 561 
selection on 5-FOA plates. The bolded and underlined sequence is the targeted N20 site, 562 
the red underlined is the PAM sequence, and the mutated nucleotides are highlighted in 563 
green.  564 
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 565 
Figure 3: Base editing efficiency was improved by pCBEclos-opt carrying the 566 
codon optimized Apobec1 and UGI. (A) Sequence alignment of the pyrE mutants 567 
obtained by transformation with pCBEclos-cbei1006-g1-opt; (B) C. beijerinckii 568 
carrying the plasmid pCBEclos-cbei1006-g1-opt were patched on plates containing 5-569 
FOA, “-” represents the negative control; (C) Sequence alignment of the pyrE mutants 570 
isolated after re-streaking mixed colonies on CGM+ erythromycin plate; (D) The ratio 571 
of positive transformants and 5-FOA resistant strains was compared between the 572 
pCBEclos and pCBEclos-opt. The bolded and underlined sequence is the targeted N20 573 
site, the red underlined is the PAM sequence, and the mutated nucleotides are 574 
highlighted in green.  575 
 576 
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 577 
Figure 4: Mutagenesis of gene araR and xylR in C. beijerinckii NCIMB 8052 via 578 
pCBEclos-opt system. (A) Sequence alignment of the araR mutants obtained by 579 
transformation with pCBEclos-cbei3835-g1-opt; (B) The pure araR mutant was 580 
obtained after single-round streaking the mixed colony on plate. (C) Sequence 581 
alignment of the xylR mutants obtained by transformation with pCBEclos-cbei2385-582 
g1-opt. (D) The pure xylR mutant was isolated by single-round streaking a mixed 583 
colony on plate. The bolded and underlined sequence is the targeted N20 site, the red 584 
underlined is the PAM sequence, and the mutated nucleotides are highlighted in green.  585 
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 586 
Figure 5: Pure mutants were obtained directly from the transformants of C. 587 
beijerinckii NCIMB 8052 via plasmid pCBEclos-opt. (A) Sequence alignment of the 588 
xylR pure mutant obtained by transformation with pCBEclos-cbei2385-g2-opt; (B) 589 
Sequence alignment of the spo0A pure mutant obtained by transformation with 590 
pCBEclos-spo0A-g2-opt. The bolded and underlined sequence is the targeted N20 site, 591 
the red underlined is the PAM sequence, and the mutated nucleotides are highlighted in 592 
green.  593 
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Supporting information, Table S1: Plasmids and strains used in this study. 606 
Strains or plasmids Description Source or reference 
Strains   
C. beijerinckii NCIMB 8052 Wild type NCIMB 
E. coli DH5α   Commercial transformation host GIBCO BRL, Life 
Technologies 
Plasmids   
pXY1 pCB102, MLSR, Pthl promotor,ColE1 origin , Amp
R, E.coli-Clostridium shuttle vector This study 
pCBEclos-cbei1006-g1 Derived from pXY1-Cas9n, pJ23119-sgRNA1-cbei1006, Pthl-rAPOBEC1-XTEN Cas9n-
UGI 
This study 
pCBEclos-cbei1006-g2 Derived from pCBEclos-cbei1006-g1, pJ23119-sgRNA2-cbei1006 This study 
pCBEclos-cbei1006-g3 Derived from pCBEclos-cbei1006-g1, pJ23119-sgRNA3-cbei1006 This study 
pCBEclos-cbei1006-g1-opt Derived from pCBEclos-cbei1006-g1, Pthl-rAPOBEC1(optimized)-XTEN Cas9n-
UGI(optimized) 
This study 
pCBEclos-cbei4456-g1-opt Derived from pCBEclos-cbei1006-g1-opt, Pthl-rAPOBEC1(optimized)-XTEN Cas9n-
UGI(optimized) 
This study 
pCBEclos-cbei2385-g1-opt Derived from pCBEclos-cbei1006-g1-opt, Pthl-rAPOBEC1(optimized)-XTEN Cas9n-
UGI(optimized) 
This study 
pCBEclos-cbei2385-g2-opt Derived from pCBEclos-cbei1006-g1, Pthl-rAPOBEC1(optimized)-XTEN Cas9n-
UGI(optimized) 
This study 
pCBEclos-cbei1712-opt Derived from pCBEclos-cbei1006-g1-opt, pJ23119-sgRNA-cbei1712 This study 
 607 
 608 
 609 
Supporting information, Table S2: Oligonucleotides used in this study. 610 
Oligos Sequence (5’→3’) 
cbei1006-gRNA1-up1 aggtataatactagtattctccaagtcttcttaacgttttagagctagaaatagcaagt 
cbei1006-gRNA1-up2 aatgtgctgcattgacagctagctcagtcctaggtataatactagtattctccaagtct 
BE-gRNA-dn ctattattatttttatcaatatattttgttaaaaaggtaccaaaaaagcaccgactcgg 
BE-Pthl-up agtcggtgcttttttggtacctttttaacaaaatatattgataaaaataataatagtgg 
BE-Pthl-dn(apo-hm) gccactgggccagtctctgagctcatggatcctctaactaacctcctaaattttgatac 
Apobec1-hm-up gttaccccgtatcaaaatttaggaggttagttagaggatccatgagctcagagactggc 
Apobec1-hm-dn cgctatttgtgccgatagctaagcctattgagtatttcttatcactttcgggtgtggcg 
Cas9nclos-up cccgggacctcagagtccgccacacccgaaagtgataagaaatactcaataggcttagc 
Cas9nclos-dn tccttttcaataatatctgacagattagtagaaccaccagagtcacctcctagctgact 
UGI-hm-up tgaaacacgcattgatttgagtcagctaggaggtgactctggtggttctactaatctgt 
UGI-hm-dn gtcacgacgttgtaaaacgacggccagtgaattcccgggttaagaaccaccagagagca 
 34 
cbei1006-gRNA2-
up(A-up) 
attgacagctagctcagtcctaggtataatactagtaacttccgccattgtaactagttttagagctagaaatagcaag 
cbei1006-gRNA3-
up(A-up) 
attgacagctagctcagtcctaggtataatactagtttgtgccatagttacaatgggttttagagctagaaatagcaag 
pBEclos-A-dn ttgactacttcttcacttgga 
pBEclos-B-up gttctgataaaaatcgtggtaaa 
pBEclos-B-dn atcctttgatcttttctacgg 
pBEclos-C-up taacgtgagttttcgttcca 
pBEclos-C-dn actagtattatacctaggactgag 
Apobec1-opt-up ttaccccgtatcaaaatttaggaggttagttagaggatccatgtcaagtgaaacaggac 
Apobec1-opt-dn tatttgtgccgatagctaagcctattgagtatttcttatcagattcaggagttgcagat 
Cas9nclos-up(for opt) ccaggaacatcagaatctgcaactcctgaatctgataagaaatactcaataggcttagc 
Cas9nclos-dn(for opt) tctttttctattatatctgaaagatttgttgatcctccactgtcacctcctagctgact 
UGI-opt-up tttatgaaacacgcattgatttgagtcagctaggaggtgacagtggaggatcaacaaat 
UGI-opt-dn cgacgttgtaaaacgacggccagtgaattcccgggttatgatcctccagataacatttt 
cbe44565-gRNA1-
up(A-up) 
attgacagctagctcagtcctaggtataatactagtcttattcccatttcttctttgttttagagctagaaatagcaag 
cbei2385-gRNA1-
up(A-up) 
attgacagctagctcagtcctaggtataatactagtgcttcattatctacatatacgttttagagctagaaatagcaag 
cbei2385-gRNA2-
up(A-up) 
attgacagctagctcagtcctaggtataatactagtagatcgttggaatctacagggttttagagctagaaatagcaag 
cbei2385-verf-up ttgatagaagtaaatcacagtaaaataaaag 
cbei2385-verf-dn gaagcatacacatctatgaattctc 
cbei1712-gRNA-up(A-
up) 
attgacagctagctcagtcctaggtataatactagtggctcctattgatttagaaagttttagagctagaaatagcaag 
cbei4456-verf-up gggttacataaaggccct 
cbei4456-verf-dn ttaaactctagaacaagaatctctaaca 
cbei1006-verf-up acgagattataggaataatataaattgatc 
cbei1006-verf-dn tcacagtcctgagaaacatatat 
cbei1712-verf-up atacaatgcaattggaaaaggt 
cbei1712-verf-dn atttgttggcttacctttatcat 
The bolded and underlined sequence represent the target sites used in base editing. 611 
 612 
 613 
 614 
Supporting information, Figure. S1: Schematic for construction of pCBEclos 615 
series plasmids. 616 
 35 
 617 
Primers pBEclos-B-up/pBEclos-B-dn, pBEclos-C-up/pBEclos-C-dn are used to 618 
amplify the universal fragments BEclos-B-opt(part B), BEclos-C-opt(part C). Only the 619 
part A is changed for the construction of new plasmid by the primer gRNA-up(A-up) 620 
and the universal primer pBEclos-A-dn. Then, part A, part B and part C are assembled 621 
to generated the new base editing plasmid. 622 
 623 
Supporting information, Figure. S2: Target sites on pyrE gene were changed to 624 
test the pCBEclos system. 625 
 36 
 626 
(A) The sequence of target sites in the pyrE gene; (B) C. beijerinckii were spread on 627 
plates containing 5-FOA after transformation with plasmid pCBEclos-cbei1006-g2 and 628 
pCBEclos-cbei1006-g3; Strains 1-22 are the transformants of plasmid pCBEclos-629 
cbei1006-g2, while strains 1’-11’ are the transformants of plasmid pCBEclos-cbei1006-630 
g3; “+” represents the positive control; (C) Sequence alignment of the pyrE mutants 631 
edited by pCBEclos system after selection on 5-FOA plates. The bolded and underlined 632 
sequence is the targeted N20 site, the red underlined is the PAM sequence, and the 633 
mutated nucleotides are highlighted in green.  634 
 635 
Supporting information, Figure. S3: Clearance of plasmid pCBEclos-cbei1006-g1-636 
opt. 637 
 37 
 638 
 639 
 640 
 641 
Supporting information, Figure. S4: Purification of the mixed xylR and spo0A 642 
mutants on plates. 643 
 38 
 644 
(A) Sequence alignment of the pure xylR mutants after streaking the mixed strain on  645 
plate. (B) Sequence alignment of the pure spo0A mutants after streaking the mixed 646 
strain on plate. 647 
 648 
 649 
Supporting information, Figure. S5: Clearance of plasmid pCBEclos-cbei2385-g2-650 
opt and the xylose consumption of 8052WT, 8052xylR(TargeTron) and 651 
8052xylR(BE). 652 
 39 
 653 
(A) Clearance of plasmid pCBEclos-cbei2385-g2-opt. (B) Xylose consumption of  654 
strains 8052WT, 8052xylR(TargeTron) (xylR was disrupted by TargeTron technology) 655 
and 8052xylR(BE) ( xylR was disrupted by pCBE-opt) in XHP2 medium containing 60 656 
g/l D-xylose. Samples were taken after 72 h of fermentation. Fermentations were 657 
performed in triplicate. 658 
 659 
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 665 
